United States Biotechnology & Medical Research

TetraLogic Pharmaceuticals Corp (TLOG)

Track

Stock chart
Ticker: TLOG Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Clarus Lifesciences II, L.P.
1 sale — total 36,881 USD
Sale 9 Feb 2016
Value US$4,643,011.47 | Price 229.08 | Shares 88,144
Sale 8 Feb 2016
Value US$2,616,298.19 | Price 102.79 | Shares 92,490
Sale 5 Feb 2016
Value US$166,576.20 | Price 0.20 | Shares 832,881
Sale 4 Feb 2016
Value US$70,003.64 | Price 0.14 | Shares 500,026
Sale 3 Feb 2016
Value US$12,387.45 | Price 0.15 | Shares 82,583
Sale 2 Feb 2016
Value US$29,972.02 | Price 0.17 | Shares 176,306
Sale 1 Feb 2016
Value US$28,000.00 | Price 0.20 | Shares 140,000
Sale 29 Jan 2016
Value US$13,734.76 | Price 0.26 | Shares 52,826
Sale 28 Jan 2016
Value US$8,455.46 | Price 0.26 | Shares 32,521
Sale 27 Jan 2016
Value US$56,695.68 | Price 0.27 | Shares 209,984
Sale 26 Jan 2016
Value US$20,827.50 | Price 0.30 | Shares 69,425
Buy 10 Jul 2015
Value US$25,668.00 | Price 2.79 | Shares 9,200
Buy 10 Jul 2015
Value US$2,200.00 | Price 2.75 | Shares 800
Buy 10 Jul 2015
Value US$20,883.96 | Price 2.75 | Shares 7,608
Buy 10 Jul 2015
Value US$18,926.70 | Price 2.74 | Shares 6,900
Buy 10 Jul 2015
Value US$27,370.00 | Price 2.74 | Shares 10,000
Buy 10 Jul 2015
Value US$5,649.00 | Price 2.69 | Shares 2,100
Buy 10 Jul 2015
Value US$2,414.37 | Price 2.66 | Shares 908
Buy 10 Jul 2015
Value US$2,893.80 | Price 2.65 | Shares 1,092
Buy 10 Jul 2015
Value US$236.44 | Price 2.57 | Shares 92
Buy 10 Jul 2015
Value US$3,302.00 | Price 2.54 | Shares 1,300
Buy 10 Jul 2015
Value US$24,400.00 | Price 2.44 | Shares 10,000
Buy 9 Jul 2015
Value US$24,090.00 | Price 2.41 | Shares 10,000
Buy 9 Jul 2015
Value US$96,000.00 | Price 2.40 | Shares 40,000
Buy 2 Jul 2015
Value US$15,187.90 | Price 2.34 | Shares 6,500
Buy 2 Jul 2015
Value US$8,169.00 | Price 2.33 | Shares 3,500
Buy 27 Mar 2015
Value US$21,750.00 | Price 4.35 | Shares 5,000
Buy 26 Mar 2015
Value US$21,147.50 | Price 4.23 | Shares 5,000
Buy 7 Jan 2015
Value US$25,181.00 | Price 5.04 | Shares 5,000
Buy 10 Dec 2014
Value US$36,344.00 | Price 6.16 | Shares 5,900
Buy 9 Dec 2014
Value US$30,060.00 | Price 6.01 | Shares 5,000
Buy 4 Dec 2014
Value US$5,107.96 | Price 4.94 | Shares 1,034
Buy 2 Dec 2014
Value US$49,900.00 | Price 4.99 | Shares 10,000
Buy 26 Nov 2014
Value US$5,351.94 | Price 4.87 | Shares 1,100
Buy 26 Nov 2014
Value US$4,900.00 | Price 4.90 | Shares 1,000
Buy 26 Nov 2014
Value US$4,810.00 | Price 4.81 | Shares 1,000
Buy 26 Nov 2014
Value US$97,970.00 | Price 4.90 | Shares 20,000
Buy 25 Nov 2014
Value US$484.00 | Price 4.84 | Shares 100
Buy 25 Nov 2014
Value US$968.00 | Price 4.84 | Shares 200
Buy 25 Nov 2014
Value US$2,423.50 | Price 4.85 | Shares 500
Buy 25 Nov 2014
Value US$2,422.50 | Price 4.85 | Shares 500
Buy 25 Nov 2014
Value US$3,408.93 | Price 4.87 | Shares 700
Buy 18 Nov 2014
Value US$48,185.00 | Price 4.82 | Shares 10,000
Buy 17 Nov 2014
Value US$90,640.00 | Price 4.53 | Shares 20,000
Buy 12 Nov 2014
Value US$19,890.00 | Price 3.98 | Shares 5,000
Buy 11 Nov 2014
Value US$39,325.00 | Price 3.93 | Shares 10,000
Buy 10 Nov 2014
Value US$41,352.00 | Price 4.14 | Shares 10,000
Buy 10 Nov 2014
Value US$40,630.00 | Price 4.06 | Shares 10,000
Buy 17 Dec 2013
Value US$42,553.00 | Price 7.00 | Shares 6,079
Buy 17 Dec 2013
Value US$85,113.00 | Price 7.00 | Shares 12,159
Buy 17 Dec 2013
Value US$1,702,323.00 | Price 7.00 | Shares 243,189
Buy 17 Dec 2013
Value US$9,975,441.00 | Price 7.00 | Shares 1,425,063
Buy 17 Dec 2013
Value US$1,999,998.00 | Price 7.00 | Shares 285,714
Buy 17 Dec 2013
Value US$185,857.00 | Price 7.00 | Shares 26,551
Buy 17 Dec 2013
Value US$999,999.00 | Price 7.00 | Shares 142,857
Buy 17 Dec 2013
Value US$3,116,253.00 | Price 7.00 | Shares 445,179
Buy 17 Dec 2013
Value US$999,999.00 | Price 7.00 | Shares 142,857
Buy 17 Dec 2013
Value US$1,904,994.00 | Price 7.00 | Shares 272,142
Buy 17 Dec 2013
Value US$4,994,241.00 | Price 7.00 | Shares 713,463
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-02-10 2016-02-09 S Sale Clarus Lifesciences II, L.P. Large shareholder
88,144 +10.2%
229.08
US$4,643,011 		88,144 +10.2% 229.08 US$4,643,011
2016-02-10 2016-02-08 S Sale Clarus Lifesciences II, L.P. Large shareholder
92,490 +35.2%
102.79
US$2,616,298 		92,490 +35.2% 102.79 US$2,616,298
2016-02-05 2016-02-05 S Sale Clarus Lifesciences II, L.P. Large shareholder
5,513 -1.8%
183.12
US$4,222,676 		5,513 -1.8% 183.12 US$4,222,676
2016-02-05 2016-02-04 S Sale Clarus Lifesciences II, L.P. Large shareholder
500,026 -12.9%
0.14
US$70,004 		500,026 -12.9% 0.14 US$70,004
2016-02-05 2016-02-03 S Sale Clarus Lifesciences II, L.P. Large shareholder
82,583 -2.1%
0.15
US$12,387 		82,583 -2.1% 0.15 US$12,387
2016-02-02 2016-02-02 S Sale Clarus Lifesciences II, L.P. Large shareholder
176,306 -4.3%
0.17
US$29,972 		176,306 -4.3% 0.17 US$29,972
2016-02-02 2016-02-01 S Sale Clarus Lifesciences II, L.P. Large shareholder
140,000 -3.3%
0.20
US$28,000 		140,000 -3.3% 0.20 US$28,000
2016-02-02 2016-01-29 S Sale Clarus Lifesciences II, L.P. Large shareholder
52,826 -1.2%
0.26
US$13,735 		52,826 -1.2% 0.26 US$13,735
2016-01-28 2016-01-28 S Sale Clarus Lifesciences II, L.P. Large shareholder
32,521 -0.7%
0.26
US$8,455 		32,521 -0.7% 0.26 US$8,455
2016-01-28 2016-01-27 S Sale Clarus Lifesciences II, L.P. Large shareholder
209,984 -4.6%
0.27
US$56,696 		209,984 -4.6% 0.27 US$56,696
2016-01-28 2016-01-26 S Sale Clarus Lifesciences II, L.P. Large shareholder
69,425 -1.5%
0.30
US$20,828 		69,425 -1.5% 0.30 US$20,828
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
9,200 +5.2%
2.79
US$25,668 		9,200 +5.2% 2.79 US$25,668
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
800 +0.5%
2.75
US$2,200 		800 +0.5% 2.75 US$2,200
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
7,608 +4.5%
2.75
US$20,884 		7,608 +4.5% 2.75 US$20,884
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
6,900 +4.3%
2.74
US$18,927 		6,900 +4.3% 2.74 US$18,927
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
10,000 +6.7%
2.74
US$27,370 		10,000 +6.7% 2.74 US$27,370
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
2,100 +1.4%
2.69
US$5,649 		2,100 +1.4% 2.69 US$5,649
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
908 +0.6%
2.66
US$2,414 		908 +0.6% 2.66 US$2,414
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
1,092 +0.7%
2.65
US$2,894 		1,092 +0.7% 2.65 US$2,894
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
92 +0.1%
2.57
US$236 		92 +0.1% 2.57 US$236
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
1,300 +0.9%
2.54
US$3,302 		1,300 +0.9% 2.54 US$3,302
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
10,000 +7.4%
2.44
US$24,400 		10,000 +7.4% 2.44 US$24,400
2015-07-13 2015-07-09 B Purchase Pecora Andrew L Non-Executive Director
10,000 +8.0%
2.41
US$24,090 		10,000 +8.0% 2.41 US$24,090
2015-07-13 2015-07-09 B Purchase Pecora Andrew L Non-Executive Director
40,000 +47.2%
2.40
US$96,000 		40,000 +47.2% 2.40 US$96,000
2015-07-06 2015-07-02 B Purchase Schmitt Paul J Non-Executive Director
6,500 +48.1%
2.34
US$15,188 		6,500 +48.1% 2.34 US$15,188
2015-07-06 2015-07-02 B Purchase Schmitt Paul J Non-Executive Director
3,500 +35.0%
2.33
US$8,169 		3,500 +35.0% 2.33 US$8,169
2015-03-31 2015-03-27 B Purchase Meyers Pete A.

CFO & Treasurer

Officer
5,000 +3.4%
4.35
US$21,750 		5,000 +3.4% 4.35 US$21,750
2015-03-30 2015-03-26 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
5,000 +1.5%
4.23
US$21,148 		5,000 +1.5% 4.23 US$21,148
2015-01-09 2015-01-07 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
5,000 +1.6%
5.04
US$25,181 		5,000 +1.6% 5.04 US$25,181
2014-12-12 2014-12-10 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
5,900 +3.1%
6.16
US$36,344 		5,900 +3.1% 6.16 US$36,344
2014-12-11 2014-12-09 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
5,000 +1.6%
6.01
US$30,060 		5,000 +1.6% 6.01 US$30,060
2014-12-08 2014-12-04 B Purchase Meyers Pete A.

CFO & Treasurer

Officer
1,034 +0.7%
4.94
US$5,108 		1,034 +0.7% 4.94 US$5,108
2014-12-04 2014-12-02 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
10,000 +3.3%
4.99
US$49,900 		10,000 +3.3% 4.99 US$49,900
2014-12-01 2014-11-26 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
1,100 +inf%
4.87
US$5,352 		1,100 +inf% 4.87 US$5,352
2014-12-01 2014-11-26 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
1,000 +0.5%
4.90
US$4,900 		1,000 +0.5% 4.90 US$4,900
2014-12-01 2014-11-26 B Purchase Russell Lesley

Chief Operating Officer

Officer
20,000 +inf%
4.90
US$97,970 		20,000 +inf% 4.90 US$97,970
2014-12-01 2014-11-26 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
1,000 +0.5%
4.81
US$4,810 		1,000 +0.5% 4.81 US$4,810
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
100 +0.1%
4.84
US$484 		100 +0.1% 4.84 US$484
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
200 +0.1%
4.84
US$968 		200 +0.1% 4.84 US$968
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
500 +0.3%
4.85
US$2,424 		500 +0.3% 4.85 US$2,424
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
500 +0.3%
4.85
US$2,422 		500 +0.3% 4.85 US$2,422
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
700 +0.4%
4.87
US$3,409 		700 +0.4% 4.87 US$3,409
2014-11-20 2014-11-18 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
10,000 +3.4%
4.82
US$48,185 		10,000 +3.4% 4.82 US$48,185
2014-11-19 2014-11-17 B Purchase Pecora Andrew L Non-Executive Director
20,000 +30.8%
4.53
US$90,640 		20,000 +30.8% 4.53 US$90,640
2014-11-13 2014-11-12 B Purchase Meyers Peter A.

CFO & Treasurer

Officer
5,000 +3.5%
3.98
US$19,890 		5,000 +3.5% 3.98 US$19,890
2014-11-13 2014-11-11 B Purchase BUCHI J KEVIN

President and CEO

Executive Director
10,000 +3.5%
3.93
US$39,325 		10,000 +3.5% 3.93 US$39,325
2014-11-12 2014-11-10 B Purchase Schmitt Paul J Non-Executive Director
10,000 +inf%
4.14
US$41,352 		10,000 +inf% 4.14 US$41,352
2014-11-12 2014-11-10 B Purchase Schmitt Paul J Non-Executive Director
10,000 +inf%
4.06
US$40,630 		10,000 +inf% 4.06 US$40,630
2013-12-19 2013-12-17 B Purchase Woody James N. Non-Executive Director
6,079 +2.4%
7.00
US$42,553 		6,079 +2.4% 7.00 US$42,553
2013-12-19 2013-12-17 B Purchase Woody James N. Non-Executive Director
12,159 +5.0%
7.00
US$85,113 		12,159 +5.0% 7.00 US$85,113
2013-12-19 2013-12-17 B Purchase Woody James N. Non-Executive Director
243,189 +inf%
7.00
US$1,702,323 		243,189 +inf% 7.00 US$1,702,323
2013-12-19 2013-12-17 B Purchase Clarus Lifesciences II, L.P. Large shareholder
1,425,063 +inf%
7.00
US$9,975,441 		1,425,063 +inf% 7.00 US$9,975,441
2013-12-19 2013-12-17 B Purchase BUCHI J KEVIN

President and CEO

Executive Director
285,714 +inf%
7.00
US$1,999,998 		285,714 +inf% 7.00 US$1,999,998
2013-12-19 2013-12-17 B Purchase Pecora Andrew L Non-Executive Director
26,551 +164.1%
7.00
US$185,857 		26,551 +164.1% 7.00 US$185,857
2013-12-19 2013-12-17 B Purchase Meyers Peter A.

CFO & Treasurer

Officer
142,857 +inf%
7.00
US$999,999 		142,857 +inf% 7.00 US$999,999
2013-12-19 2013-12-17 B Purchase Schmitt Paul J Non-Executive Director
445,179 +inf%
7.00
US$3,116,253 		445,179 +inf% 7.00 US$3,116,253
2013-12-19 2013-12-17 B Purchase Reed Douglas MD Non-Executive Director
142,857 +inf%
7.00
US$999,999 		142,857 +inf% 7.00 US$999,999
2013-12-18 2013-12-17 B Purchase AMGEN INC Large shareholder
272,142 +101.1%
7.00
US$1,904,994 		272,142 +101.1% 7.00 US$1,904,994
2013-12-17 2013-12-17 B Purchase HEALTHCARE VENTURES VII LP Large shareholder
713,463 +38.1%
7.00
US$4,994,241 		713,463 +38.1% 7.00 US$4,994,241
Explore more

More insider trading research around TetraLogic Pharmaceuticals Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America